Real-World Treatment Patterns After CD19-Directed CAR T Cell Therapy Among Patients with Diffuse Large B Cell Lymphoma

por Jalbert, Jessica J., Wu, Ning, Chen, Chieh-I, Ambati, Srikanth, Ge, Wenzhen, Arnason, Jon E.
Publicado 2022

Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model

por Villasante, Aranzazu, Marturano-Kruik, Alessandro, Ambati, Srikanth R., Liu, Zen, Godier-Furnemont, Amandine, Parsa, Hesam, Lee, Benjamin W., Moore, Malcolm A.S., Vunjak-Novakovic, Gordana
Publicado 2016

PB2279: TRIAL IN PROGRESS: ODRONEXTAMAB, A CD20×CD3 BISPECIFIC ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MZL) – A COHORT FROM THE ELM...

por Cho, Seok-Goo, Kim, Tae Min, Taszner, Michał, Chen, Tsai Yun, Chaudhry, Aafia, Ufkin, Melanie, Uppala, Amulya, Sabir, Ayesha, Mohamed, Hesham, Ambati, Srikanth, Bachy, Emmanuel
Publicado 2023

BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models

por Ambati, Srikanth R., Shieh, Jae-Hung, Pera, Benet, Lopes, Eloisi Caldas, Chaudhry, Anisha, Wong, Elissa W.P., Saxena, Ashish, Su, Tsann-Long, Moore, Malcolm A.S.
Publicado 2016

PB2275: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHEMOTHERAPY VERSUS RITUXIMAB PLUS CHEMOTHERAPY IN PREVIOUSLY UNTREATED FOLLICULAR...

por Novelli, Silvana, Risal, Ashish, Namuduri, Manjusha, Cai, Jingxian, Ufkin, Melanie, Zhu, Min, Mukherjee, Sushmita, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Iskierka-Jażdżewska, Elżbieta
Publicado 2023

PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1)

por Luminari, Stefano, Kim, Tae Min, Risal, Ashish, Namuduri, Manjusha, Cai, Jingxian, Fearon-Chalet, Bertha, Zhu, Min, Mukherjee, Sushmita, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Vitolo, Umberto
Publicado 2023

Complete responses to odronextamab in two patients with diffuse large B‐cell lymphoma refractory to chimeric antigen receptor T‐cell therapy

por Weinstock, Matt, Elavalakanar, Pavania, Bright, Susan, Ambati, Srikanth R., Brouwer‐Visser, Jurriaan, Pourpe, Stephane, Fiaschi, Nathalie, Jankovic, Vladimir, Thurston, Gavin, Deering, Raquel P., Chaudhry, Aafia, Joyce, Robin, Arnason, Jon
Publicado 2022

PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYM...

por Hawkes, Eliza A., Kim, Tae Min, Namuduri, Manjusha, Risal, Ashish, Shen, Biyi, Flink, Dina, Zhu, Min, Nolan, Siobhán, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Ambati, Srikanth, Mohamed, Hesham, Cho, Seok-Goo
Publicado 2023

PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (...

por Tessoulin, Benoit, Guidez, Stephanie, Namuduri, Manjusha, Risal3, Ashish, Waldron, Alpana, Sophos, Nickolas A., Uppala, Amulya, Zhu, Min, Nolan, Siobhán, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Ambati, Srikanth, Mohamed, Hesham, Tucker, David
Publicado 2023

PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA...

por Vitolo, Umberto, Phillips, Elizabeth H., Alonso, Aránzazu Alonso, Merli, Michele, Risal, Ashish, Namuduri, Manjusha, Shen, Biyi, Flink, Dina, Zhu, Min, Mukherjee, Sushmita, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Cordoba, Raul
Publicado 2023

Translational findings for odronextamab: From preclinical research to a first‐in‐human study in patients with CD20+ B‐cell malignancies

por Zhu, Min, Olson, Kara, Kirshner, Jessica R., Khaksar Toroghi, Masood, Yan, Hong, Haber, Lauric, Meagher, Craig, Flink, Dina M., Ambati, Srikanth R., Davis, John D., DiCioccio, A. Thomas, Smith, Eric J., Retter, Marc W.
Publicado 2022

PB2357: TRIAL IN PROGRESS: OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH SYSTEMIC THERAPY FROM REAL-WORLD EXPERIENCE (ORCHID)

por Thieblemont, Catherine, MA, Qiufei, Hampp, Christian, Harnett, James, Sobel, Rachel E, Jalbert, Jessica J, Quek, Ruben Gw, Wei, Wenhui, Wu, Ning, Mastey, Vera, Wang, Joy, Bajwa, Anit, Maissenhaelter, Benedikt, van Gils, Chantal, Aggarwal, Shivani, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Bachy, Emmanuel, Damaj, Gandhi Laurent
Publicado 2023

PB2281: TRIAL IN PROGRESS: FOLLICULAR LYMPHOMA OUTCOMES IN RELAPSED/REFRACTORY PATIENTS TREATED WITH SYSTEMIC THERAPY IN A REAL-WORLD ASSESSMENT (FLORA)

por Damaj, Gandhi Laurent, Bachy, Emmanuel, MA, Qiufei, Hampp, Christian, Harnett, James, Sobel, Rachel E, Jalbert, Jessica J, Quek, Ruben Gw, Wei, Wenhui, Wu, Ning, Mastey, Vera, Wang, Joy, Bajwa, Anit, Maissenhaelter, Benedikt, van Gils, Chantal, Aggarwal, Shivani, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Thieblemont, Catherine
Publicado 2023

P1083: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2

por Taszner, Michał, Luminari, Stefano, Cho, Seok-Goo, Novelli, Silvana, Le Gouill, Steven, Poon, Michelle, Villasboas, Jose, Champion, Rebecca, Bachy, Emmanuel, Guidez, Stephanie, Alonso Alonso, Aránzazu, Jagadeesh, Deepa, Merli, Michele, Tucker, David, Cai, Jingxian, Leite de Oliveira, Carolina, Zhu, Min, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Min Kim, Tae
Publicado 2023

P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2

por Walewski, Jan, Min Kim, Tae, Cho, Seok-Goo, Jarque, Isidro, Iskierka-Jażdżewska, Elżbieta, Poon, Michelle, Miles Prince, H., Yong Oh, Sung, Lim, Francesca, Segura, Cecilia Carmen Carpio, Tan, Tran-Der, Ayyappan, Sabarish, Gutiérrez, Antonio, LI, Jingjin, Ufkin, Melanie, Zhu, Min, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Kim, Won-Seog
Publicado 2023